Unique ID issued by UMIN | UMIN000028391 |
---|---|
Receipt number | R000032501 |
Scientific Title | Effectiveness and safety of bronchial thermoplasty multicenter study in Japan |
Date of disclosure of the study information | 2017/07/29 |
Last modified on | 2023/01/29 09:22:06 |
Effectiveness and safety of bronchial
thermoplasty multicenter study in Japan
Bronchial thermoplasty multicenter study
in Japan
Effectiveness and safety of bronchial
thermoplasty multicenter study in Japan
Bronchial thermoplasty multicenter study
in Japan
Japan |
Severe asthma
Pneumology |
Others
NO
To clarify the effectiveness and safety ofbronchial thermoplasty for severe asthma
in Japanese multicenter study.
Safety,Efficacy
QOL (quality of life)
1.Asthma exacerbation
2.Emergency room visits
3.Unscheduled physician office visits
4.Hospitalization frequency
5.Hospitalizations
6.Days missed from work/school
7.Physician's Global Evaluation of
Treatment Effectiveness (GETE)
assessment
8.Therapeutic drug use
9.Pulmonary function
10.Adverse events
Observational
18 | years-old | <= |
Not applicable |
Male and Female
1. Uncontrolled severe asthma patients
treated with high dose inhaled
corticosteroid and long-acting
beta2-agonists
2. Eligible for fiberoptic bronchoscopy
1. Have a pacemaker, implantable
cardioverter defibrillator, or other
implantable electronic device.
2. Have a known sensitivity to
medications required to perform
bronchoscopy, including lidocaine,
atropine, and benzodiazepines.
3. Have been previously treated with BT
4. Active respiratory infection
5. Asthma exacerbation or changing doseof systemic corticosteroids for asthma
in the past 14 days
6. Known coagulopathy. As with other
bronchoscopic procedures, patients should stop taking anticoagulants,
antiplatelet agents, aspirin, and
NSAIDS before the procedure with
physician guidance
200
1st name | Akihiro |
Middle name | none |
Last name | Takemasa |
Dokkyo Medical University School of
Medicine
Department of Pulmonary Medicine and Clinical Immunology
3210293
880 Kitakobayashi, Mibu, Tochigi
0282861111
takemasa@dokkyomed.ac.jp
1st name | Akihiro |
Middle name | none |
Last name | Takemasa |
Dokkyo Medical University School of Medicine
Department of Pulmonary Medicine and Clinical Immunology
3210293
880 Kitakobayashi, Mibu, Tochigi
0282861111
https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000032501
takemasa@dokkyomed.ac.jp
Department of Pulmonary Medicine and
Clinical Immunology, Dokkyo Medical
University School of Medicine
Dokkyo Medical University School of Medicine
Self funding
Japan
Boston Scietific Japan Co. Ltd
Boston Scietific Japan Co. Ltd
Dokkyo Medical University School of Medicine
880 Kitakobayashi, Mibu, Tochigi, Japan
0282-86-1111
m-syouji@dokkyomed.ac.jp
NO
獨協医科大学(栃木県)
2017 | Year | 07 | Month | 29 | Day |
https://center6.umin.ac.jp/cgi-bin/icdr/ctr_view_reg.cgi?recptno=R000032501
Unpublished
226
Delay expected |
Re-analysis is currently underway and will be published after the paper is submitted.
2023 | Year | 12 | Month | 30 | Day |
Preinitiation
2017 | Year | 05 | Month | 31 | Day |
2017 | Year | 05 | Month | 07 | Day |
2017 | Year | 08 | Month | 28 | Day |
2020 | Year | 12 | Month | 30 | Day |
2020 | Year | 12 | Month | 30 | Day |
2020 | Year | 12 | Month | 30 | Day |
2020 | Year | 12 | Month | 30 | Day |
Retrospective and prospective study
2017 | Year | 07 | Month | 26 | Day |
2023 | Year | 01 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032501